Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

Annenberg Center for Health Sciences
  • ٠٫٠ (٠)
  • طب
Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists

In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.

الحلقات

  1. ٢٤‏/٠٨‏/١٤٤٥ هـ

    Cardiologist Collaboration

    Role in Diabetes Management Multidisciplinary Team-based Approach

    ٥ من الدقائق

  2. ٢٤‏/٠٨‏/١٤٤٥ هـ

    Individualizing Therapy

    Drug Initiation and Monitoring Contraindications and Adverse Effects Patient Education

    ٨ من الدقائق

  3. ٢٤‏/٠٨‏/١٤٤٥ هـ

    Cardiovascular Benefits

    FDA Indications Clinical Trial Evidence

    ٤ من الدقائق

  4. ٢٤‏/٠٨‏/١٤٤٥ هـ

    Glycemic/Non-Glycemic Effects

    Short-Acting versus Long-Acting Agents Fasting and Postprandial Blood Glucose Gastric Emptying and Body Weight

    ٥ من الدقائق

  5. ٢٤‏/٠٨‏/١٤٤٥ هـ

    Pathophysiologic Targets

    Diabetes Pathophysiology Glucagon-Like Peptide-1 Mechanisms

    ٥ من الدقائق

  6. ٢٤‏/٠٨‏/١٤٤٥ هـ

    Guideline Recommendations

    Diabetes Guidelines Chronic Coronary Disease Guidelines

    ١٣ من الدقائق

  7. ٢٤‏/٠٨‏/١٤٤٥ هـ

    Introduction and Case Vignettes

    Meet Jorge Plutzky, MD and Helena Rodbard, MD. This episode covers: Faculty Introduction Case Vignettes Cardiovascular Risk Reduction

    ١٢ من الدقائق
  • ٧ حلقة

حول

In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. Drawing on seminal research and their own experience, cardiologist Jorge Plutzy, MD, and endocrinologist Helena Rodbard, MD, navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease.

المعلومات

للاستماع إلى حلقات ذات محتوى فاضح، قم بتسجيل الدخول.

اطلع على آخر مستجدات هذا البرنامج

قم بتسجيل الدخول أو التسجيل لمتابعة البرامج وحفظ الحلقات والحصول على آخر التحديثات.
تحديد بلد أو منطقة

أفريقيا والشرق الأوسط، والهند

آسيا والمحيط الهادئ

أوروبا

أمريكا اللاتينية والكاريبي

الولايات المتحدة وكندا